Laboratory Corp. of America Holdings plans to spin off its unit focused on clinical drug trials, according to people familiar with the matter, a move that will create a new stand-alone company in the fast-growing contract-research sector.
Burlington, N.C.-based Labcorp is expected to unveil the plan to separate its clinical-development business Thursday when it reports its second-quarter results, the people said. Labcorp will continue its focus on its core diagnostic-testing business and will also retain two related pieces of its drug-development unit, the people said.
Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen: